This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of PDE5 inhibitors, which are widely used to treat erectile dysfunction and pulmonary arterial hypertension. Its structure is crucial for enhancing the selectivity and potency of these inhibitors, ensuring effective therapeutic outcomes. Additionally, it plays a role in research and development for exploring new treatments targeting phosphodiesterase enzymes, contributing to advancements in cardiovascular and urological medicine.